Functionally, the activation of LOXL3 plays a central driving role in the malignant progression of gastric cancer, not only enhancing the metastatic capacity of cancer cells but also promoting the formation of an invasive phenotype (Jones et al., 2018). This evidence concerns the gene LOXL3 and cancer.